ʻO Ranitidine injection

ʻO ka wehewehe pōkole:

· Kumukūʻai & Hua'ōlelo: FOB Shanghai: Kūkākūkā i loko o ke kanaka · Hoʻouna Port: Shanghai, Tianjin,Guangzhou, Qingdao · MOQ(50mg,2ml):300000amps · Uku ʻōlelo: T / T, L / C Product kiko'ī Composition ...

  • : Hoʻopili koke ʻia ʻo Ranitidine ma hope o ka hoʻokele intramuscular a he bioavailability ma kahi o 90 a 100%.ʻO ka hoʻopau ʻana i ka hapalua o ke ola mai ka plasma ma kahi o 2 a 3 mau hola a ʻo ka ranitidine i hoʻopaʻa nāwaliwali ʻia ma kahi o 15%, i nā protein plasma.
  • Huahana Huahana

    Huahana Huahana

    ·Kumukuai a me ka olelo:FOB Shanghai: Kūkākūkā ma ke kino

    ·Awa hoʻouna: Shanghai, TianjinGuangzhou, Qingdao

    ·MOQ(50mg,2ml):300000 amps

    ·Kūkākūkā uku:T/T, L/C

    Nā kikoʻī huahana

    Huina
    Aia kekahi ampoule o ranitidine i ka rannitidine hydrochloride USP XXIII 50 mg.
    Hōʻike
    ʻO Ranitidine ka histamine H2-receptor antagonist, No laila, ke kāohi nei ia i ka huna ʻana o ka ʻōpū o ka ʻōpū a hoʻemi i ka puka pepsin: ua hōʻike ʻia e kāohi i nā hana ʻē aʻe o ka histamine i hoʻopili ʻia e nā H2-receptors, ua hoʻohana ʻia i ka mālama ʻana i nā maʻi like ʻole o ka gastro-intestinal. e like me nā maʻi aspiration, dyspepsia, gastro-oesophageal reflux maʻi, peptic ulceration a me Zollinger-Ellison syndrome.

    Mālama

    Ma mua o ka hāʻawi ʻana i ka ranitidine i nā poʻe maʻi me ka maʻi ʻeha o ka ʻōpū, pono e haʻalele ʻia ka hiki ʻana o ka malignancy no ka mea hiki i ka ranitidine ke uhi i nā hōʻailona a hoʻopaneʻe i ka maʻi.Pono e hāʻawi ʻia i nā mea maʻi me ka hana renal impaired.

    Nā hopena ʻino

    ʻO nā hopena ʻaoʻao maʻamau i hōʻike ʻia ʻo ia ka diarrhoca, ka ʻūhā, ka ʻeha poʻo, a me nā ʻōpala. ʻO nā hopena ʻino ʻē aʻe, i hōʻike pinepine ʻia, ʻo ia ka hypersensilivity reactions a me ke kuni, arthralgia a me myalgia. , a me nā maʻi cardiovascular, akā naʻe, ʻaʻole like me cimetidine, he liʻiliʻi a ʻaʻohe hopena anti-andiogenic ka ranitidine, ʻoiai aia nā hōʻike kaʻawale o gyhaecomaslia a me ka maʻi ʻole.

    Ka hoʻohana ʻana a me ka hoʻokele
    Ma muli o ke ʻano o ka mālama ʻia ʻana, ʻo ka maʻa maʻamau e ka intramuscular a i ʻole intravenous injecton he 50 mg, hiki ke hana hou ʻia i kēlā me kēia 6 a 8 mau hola: pono e hāʻawi mālie ʻia ka inravenous injection ma mua o 2 mau minuke a pono e hoʻoheheʻe ʻia i loko o 50 mg i loko. ʻO 20ml no ka infusion intermittent intravenous ka mea i manaʻo ʻia ma UK he 25 mg i kēlā me kēia hola i hāʻawi ʻia no nā hola 2 i hiki ke hana hou ʻia i kēlā me kēia 6 a hiki i 8 mau hola ua manaʻo ʻia ka helu o 6.25mg i kēlā me kēia hola no ka infusion intravenous mau ʻoiai hiki ke hoʻohana ʻia nā helu kiʻekiʻe no ka. nā maʻi e like me Zollinger-Ellison syndrome a i ʻole i nā maʻi i pilikia mai ka hoʻohaʻahaʻa kaumaha.

    Waihona a me ka manawa i pau
    Halekuaima lalo o 25℃.
    3 makahiki
    Hoʻopili

    2ml*10 amps
    Hoʻopaʻa ʻana
    50mg

     


  • Mua:
  • Aʻe: